clinical trial · NCT03854552
A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.
HealthyBI 764198Placebo
brief summary
The main objective of this trial is to investigate safety and tolerability of BI 764198 in healthy male subjects following oral administration of single rising doses. Secondary objectives are the exploration of pharmacokinetics (PK) including dose proportionality of BI 764198 after single oral dosing.
started
Mar 15, 2019
primary completion
Aug 7, 2019
completion
Aug 7, 2019
last updated
Jul 6, 2026
official title
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 764198 in Healthy Male Subjects (Single-blind, Partially Randomised, Placebo-controlled, Parallel Group Design)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol